H
Hunghao Chu
Researcher at University of Pittsburgh
Publications - 19
Citations - 2277
Hunghao Chu is an academic researcher from University of Pittsburgh. The author has contributed to research in topics: Coacervate & Growth factor. The author has an hindex of 15, co-authored 19 publications receiving 2073 citations. Previous affiliations of Hunghao Chu include Boston Children's Hospital & NewYork–Presbyterian Hospital.
Papers
More filters
Journal ArticleDOI
Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice.
Erin B. Dickerson,Erik C. Dreaden,Xiaohua Huang,Ivan H. El-Sayed,Hunghao Chu,Sujatha Pushpanketh,John F. McDonald,Mostafa A. El-Sayed +7 more
TL;DR: The present work demonstrates the feasibility of in vivo PPTT treatment of deep-tissue malignancies using easily-prepared plasmonic gold nanorods and a small, portable, inexpensive near-infrared (NIR) laser.
Journal ArticleDOI
Injectable fibroblast growth factor-2 coacervate for persistent angiogenesis
TL;DR: The design and success of robust angiogenesis using an injectable polyvalent coacervate of a polycation, heparin, and fibroblast growth factor-2 (FGF2) is achieved, demonstrating the potential of polyvalents coACervate as a new controlled delivery platform.
Journal ArticleDOI
Therapeutic angiogenesis: controlled delivery of angiogenic factors.
Hunghao Chu,Yadong Wang +1 more
TL;DR: This article will highlight protein-based therapeutic angiogenesis, concisely review recent progress and examine critical challenges, and discuss growth factors that have been widely utilized in promotingAngiogenesis and compare their targets and functions.
Journal ArticleDOI
Magnetic nanoparticle labeling of mesenchymal stem cells without transfection agent: cellular behavior and capability of detection with clinical 1.5 T magnetic resonance at the single cell level.
Jong-Kai Hsiao,M.F. Tai,Hunghao Chu,Shin-Tai Chen,Hung Li,Dar-Ming Lai,Sung-Tsang Hsieh,Jaw-Lin Wang,Hon-Man Liu +8 more
TL;DR: Evaluating the efficacy of labeling human mesenchymal stem cells (hMSCs) by ionic superparamagnetic iron oxide (SPIO) without a transfection agent and verifying its capability to be detected with clinical 1.5 T magnetic resonance (MR) at the single‐cell level found it efficient and efficient.
Journal ArticleDOI
A [polycation:heparin] complex releases growth factors with enhanced bioactivity
TL;DR: A new growth factor delivery vehicle formed by self assembly of heparin and a biocompatible polycation, poly(ethylene argininylaspartate diglyceride) (PEAD) appears to be a promising delivery matrix for many heparIn-binding growth factors and may lead to efficient growth factor Delivery for a variety of diseases and disabilities.